Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

Go back to Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
(NASDAQ: TENX) Delayed: 1.90 +0.04 (2.15%)
Previous Close $1.86    52 Week High $3.40 
Open $1.92    52 Week Low $1.34 
Day High $1.97    P/E N/A 
Day Low $1.85    EPS $0.00 
Volume 7,081,079